Please login to the form below
National Institute for Health and Care Research
This page shows the latest National Institute for Health and Care Research news and features for those working in and with pharma, biotech and healthcare.
First UK proton beam therapy trial launches for certain breast cancer patients
The PARABLE trial, which will enrol 192 patients across 22 planned sites in the UK, will be led by researchers at the University of Cambridge, the Institute of Cancer Research, London ... ICR) and the Royal Marsden NHS Foundation Trust, and funded by a
Latest news
-
UK Government commit £50m to motor neurone disease research
In support of this, the National Institute for Health and Care Research (NIHR) and the Medical Research Council (MRC) will work together to ensure proposals are referred to the most appropriate ... The health and social care secretary, Steve Barclay,
-
World-first trial launches in UK to assess stem cell transplants as first-line MS treatment
The new StarMS trial, which is being funded through a National Institute for Health and Care Research and Medical Research Council partnership, will bring this research up to date and compare ... The trial will measure how good and safe AHSCT is when
-
National trial to rapidly find treatments for severe flu this winter launched in UK
A national trial aiming to use ‘pandemic lessons’ to quickly find effective treatments for patients hospitalised with severe flu has been launched in the UK. ... The £2.9m trial will work with the National Institute for Health and Care Research (NIHR
-
Infex doses first patients in Pseudomonas aeruginosa phase 1 study
Pa is a hard-to-treat drug-resistant pathogen recognised by the World Health Organization as a ‘critical threat’ to human health, the company reported, and is a leading cause of ... The phase 1 study, which is being conducted at National Institute
-
ICR calls for further discussions following NICE’s rejection of breast cancer drug
The Institute of Cancer Research (ICR) has called for further discussions between AstraZeneca (AZ), NHS England and the National Institute for Health and Care Excellence (NICE) following the decision not to ... that is affordable for the NHS and is
More from news
Approximately 6 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Innovative Trials on the latest ABPI report
This is leaving the country – and healthcare patients – on the sidelines of innovative drug development and access" according to Kate Shaw. ... The latest The Association of the British Pharmaceutical Industry (ABPI) report highlights " that
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
